Literature DB >> 11724823

Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines.

I Markovic1, E Leikina, M Zhukovsky, J Zimmerberg, L V Chernomordik.   

Abstract

At the time of fusion, membranes are packed with fusogenic proteins. Do adjacent individual proteins interact with each other in the plane of the membrane? Or does each of these proteins serve as an independent fusion machine? Here we report that the low pH-triggered transition between the initial and final conformations of a prototype fusogenic protein, influenza hemagglutinin (HA), involves a preserved interaction between individual HAs. Although the HAs of subtypes H3 and H2 show notably different degrees of activation, for both, the percentage of low pH-activated HA increased with higher surface density of HA, indicating positive cooperativity. We propose that a concerted activation of HAs, together with the resultant synchronized release of their conformational energy, is an example of a general strategy of coordination in biological design, crucial for the functioning of multiprotein fusion machines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724823      PMCID: PMC2150858          DOI: 10.1083/jcb.200103005

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  46 in total

1.  Evidence for cooperativity between nicotinic acetylcholine receptors in patch clamp records.

Authors:  A M Keleshian; R O Edeson; G J Liu; B W Madsen
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Conformational intermediates and fusion activity of influenza virus hemagglutinin.

Authors:  T Korte; K Ludwig; F P Booy; R Blumenthal; A Herrmann
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.

Authors:  G B Melikyan; R M Markosyan; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

4.  Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion.

Authors:  E Leikina; L V Chernomordik
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

5.  Comprehensive kinetic analysis of influenza hemagglutinin-mediated membrane fusion: role of sialate binding.

Authors:  A Mittal; J Bentz
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

6.  Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis.

Authors:  E Leikina; I Markovic; L V Chernomordik; M M Kozlov
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

Review 7.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

9.  Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants.

Authors:  P N Graves; J L Schulman; J F Young; P Palese
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

10.  The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.

Authors:  R T Armstrong; A S Kushnir; J M White
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  44 in total

1.  Thermal denaturation of influenza virus and its relationship to membrane fusion.

Authors:  Richard M Epand; Raquel F Epand
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin.

Authors:  Eugenia Leikina; Corinne Ramos; Ingrid Markovic; Joshua Zimmerberg; Leonid V Chernomordik
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.

Authors:  Shutoku Matsuyama; Sue Ellen Delos; Judith M White
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion.

Authors:  Stéphane Roche; Yves Gaudin
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 5.  The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement.

Authors:  F S Cohen; G B Melikyan
Journal:  J Membr Biol       Date:  2004-05-01       Impact factor: 1.843

6.  Driving a wedge between viral lipids blocks infection.

Authors:  Gregory B Melikyan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

7.  Liposome reconstitution of a minimal protein-mediated membrane fusion machine.

Authors:  Deniz Top; Roberto de Antueno; Jayme Salsman; Jennifer Corcoran; Jamie Mader; David Hoskin; Ahmed Touhami; Manfred H Jericho; Roy Duncan
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

8.  Quantitative electron microscopy and fluorescence spectroscopy of the membrane distribution of influenza hemagglutinin.

Authors:  Samuel T Hess; Mukesh Kumar; Anil Verma; Jane Farrington; Anne Kenworthy; Joshua Zimmerberg
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

Review 9.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

10.  Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function.

Authors:  Veronika von Messling; Dragana Milosevic; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.